尿肾上皮细胞流式定量特异反映急性肾脏病肾小管损伤
本研究基于CITE-Seq建立流式细胞术定量尿CD10/CD13+近端及CD227/CD326+远端肾小管上皮细胞(TEC)的方案,在243例患者中验证。远端尿TEC计数与KDIGO分期及急性eGFR丢失相关,可区分AKI与健康对照及肾小球疾病。
要点
- 尿CD227/CD326+远端TEC计数与AKI严重程度(KDIGO分期、急性eGFR丢失)相关。
- 流式定量尿TEC可区分AKI与健康对照及肾小球疾病。
- 该方案为无创监测肾小管损伤提供了新工具。
核心结论
- 尿CD227/CD326+ TEC计数可作为AKI肾小管损伤的特异性无创标志物。
研究设计与样本
- 共分析243例患者,其中8例AKI和肾小球疾病患者尿样用于单细胞测序。
- 基于CITE-Seq对齐尿单细胞转录组与TEC表面蛋白,建立流式定量CD10/CD13+近端TEC和CD227/CD326+远端TEC的方案。
- 在4个队列共235例患者中验证:AKI(n=63)、COVID-19感染(n=47)、AAV活动或稳定缓解(n=110)、健康对照(n=15)。
主要发现
- CD10/CD13和CD227/CD326分别充分识别近端TEC和远端TEC。
- 远端尿TEC计数与KDIGO分期及急性eGFR丢失相关,并在两个独立队列中验证。
- 尿TEC计数可成功区分AKI与健康对照及肾小球疾病。
关键数值与推荐
- CD10/CD13+用于识别近端TEC,CD227/CD326+用于识别远端TEC。
- AKI严重程度依据KDIGO分期和急性eGFR丢失评估。
临床怎么用
- 可考虑用流式细胞术定量尿CD227/CD326+ TEC辅助无创评估AKI肾小管损伤程度。
- 该方案为尿TEC表型深入分析提供基础。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Tubular injury is one of the main mechanisms driving acute kidney injury (AKI); however, clinicians still have a limited diagnostic repertoire to precisely monitor damage to tubular epithelial cells (TECs). In our previous study, we used single-cell sequencing to identify TEC subsets as the main components of the urine signature of AKI. This study aimed to establish TECs as clinical markers of tubular damage. METHODS: A total of 243 patients were analyzed. For sequencing, we collected 8 urine samples from patients with AKI and glomerular disease. We developed a protocol for the flow cytometric quantification of CD10/CD13+ proximal TECs (PTECs) and CD227/CD326+ distal TECs (DTECs) in urine by aligning urinary single-cell transcriptomes and TEC surface proteins using Cellular Indexing of Transcriptome and Epitope Sequencing (CITE-Seq). Marker combinations were confirmed in kidney biopsies. We validated our approach in 4 cohorts of 235 patients as follows: patients with AKI (n = 63), COVID-19 infection (n = 47), antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) with active disease or stable remission (n = 110), and healthy controls (n = 15). RESULTS: Our findings demonstrated that CD10/CD13 and CD227/CD326 adequately identified PTECs and DTECs, respectively. Distal urinary TEC counts correlate with the severity of AKI based on Kidney Disease: Improving Global Outcomes (KDIGO) stage and acute estimated glomerular filtration rate (GFR) loss in 2 separate cohorts and can successfully discriminate AKI from healthy controls and glomerular disease. CONCLUSION: We propose that urinary CD227/CD326+ TEC count is a specific, noninvasive marker for tubular injury in AKI. Our protocol provides a basis for a deeper phenotypic analysis of urinary TECs.
引用
- Wagner L, Kujat J, Langhans V, et al. Flow-Cytometric Quantification of Urine Kidney Epithelial Cells Specifically Reflects Tubular Damage in Acute Kidney Diseases. Kidney Int Rep. 2025. PMID: 40303202. doi:10.1016/j.ekir.2025.01.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。